Suppr超能文献

[初次根治性治疗后前列腺特异性抗原复发——局部还是全身?二次根治性治疗何时仍有可能?]

[PSA recurrence after primary curative therapy--local or systemic? When is a second curative therapy still possible?].

作者信息

Wirth M P, Engelhardt F M

机构信息

Klinik und Poliklinik für Urologie am Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden.

出版信息

Urologe A. 2005 Sep;44(9):997-1004, 1006-7. doi: 10.1007/s00120-005-0879-4.

Abstract

PSA recurrence after primary curative therapy for localized prostate cancer is a common problem. Further curative treatment is only reasonable in the case of local recurrence. Therefore, minimizing the likelihood of metastatic disease is crucial. So far, imaging techniques cannot distinguish between local recurrence and distant metastasis. It is therefore reasonable to orientate on PSA kinetics and pathological criteria. Histologic confirmation of suspected local recurrence after radical prostatectomy before salvage therapy is not required. However, after initial radiation therapy histologic confirmation of suspected isolated local recurrence should be obtained. The optimal treatment for a PSA recurrence depends on the initial therapy and the life-expectancy of the patient.

摘要

局限性前列腺癌初次根治性治疗后前列腺特异性抗原(PSA)复发是一个常见问题。仅在局部复发的情况下进一步进行根治性治疗才合理。因此,将发生转移性疾病的可能性降至最低至关重要。到目前为止,影像学技术无法区分局部复发和远处转移。因此,根据PSA动力学和病理标准进行判断是合理的。在挽救性治疗前,根治性前列腺切除术后疑似局部复发无需组织学证实。然而,在初始放疗后,对于疑似孤立性局部复发应获得组织学证实。PSA复发的最佳治疗方案取决于初始治疗和患者的预期寿命。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验